Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1995 1
1996 1
1997 1
1998 2
2000 2
2001 2
2002 4
2003 4
2004 2
2005 1
2006 3
2007 3
2008 5
2009 4
2010 3
2012 4
2013 2
2014 6
2015 2
2016 1
2017 4
2018 1
2019 2
2020 7
2021 2
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for slayton w[au]
Your search for Slatton W[au] retrieved no results
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.
Slayton WB, Schultz KR, Kairalla JA, Devidas M, Mi X, Pulsipher MA, Chang BH, Mullighan C, Iacobucci I, Silverman LB, Borowitz MJ, Carroll AJ, Heerema NA, Gastier-Foster JM, Wood BL, Mizrahy SL, Merchant T, Brown VI, Sieger L, Siegel MJ, Raetz EA, Winick NJ, Loh ML, Carroll WL, Hunger SP. Slayton WB, et al. J Clin Oncol. 2018 Aug 1;36(22):2306-2314. doi: 10.1200/JCO.2017.76.7228. Epub 2018 May 29. J Clin Oncol. 2018. PMID: 29812996 Free PMC article. Clinical Trial.
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial.
Hunger SP, Tran TH, Saha V, Devidas M, Valsecchi MG, Gastier-Foster JM, Cazzaniga G, Reshmi SC, Borowitz MJ, Moorman AV, Heerema NA, Carroll AJ, Martin-Regueira P, Loh ML, Raetz EA, Schultz KR, Slayton WB, Cario G, Schrappe M, Silverman LB, Biondi A. Hunger SP, et al. Among authors: slayton wb. Lancet Haematol. 2023 Jul;10(7):e510-e520. doi: 10.1016/S2352-3026(23)00088-1. Lancet Haematol. 2023. PMID: 37407142 Clinical Trial.
Stem cell research.
Sanders RC Jr, Slayton WB, Cogle CR, Fisher RC, Scott EW. Sanders RC Jr, et al. Among authors: slayton wb. Paediatr Respir Rev. 2006 Jun;7(2):135-40. doi: 10.1016/j.prrv.2006.03.009. Epub 2006 Jun 2. Paediatr Respir Rev. 2006. PMID: 16765300 Review.
Proton Therapy for Pediatric Hodgkin Lymphoma.
Wray J, Flampouri S, Slayton W, Joyce M, Sandler E, Morris CG, Li Z, Indelicato DJ, Mendenhall NP, Hoppe BS. Wray J, et al. Among authors: slayton w. Pediatr Blood Cancer. 2016 Sep;63(9):1522-6. doi: 10.1002/pbc.26044. Epub 2016 May 3. Pediatr Blood Cancer. 2016. PMID: 27149120
Early stages of hematopoietic differentiation.
Spangrude GJ, Perry SS, Slayton WB. Spangrude GJ, et al. Among authors: slayton wb. Ann N Y Acad Sci. 2003 May;996:186-94. doi: 10.1111/j.1749-6632.2003.tb03246.x. Ann N Y Acad Sci. 2003. PMID: 12799296
Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin Lymphoma.
Mailhot Vega RB, Mohammadi H, Patel SI, Holtzman AL, Lockney NA, Lynch JW, Bansal MM, Liang X, Slayton WB, Parsons SK, Hoppe BS, Mendenhall NP. Mailhot Vega RB, et al. Among authors: slayton wb. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):158-166. doi: 10.1016/j.ijrobp.2021.07.1711. Epub 2021 Aug 2. Int J Radiat Oncol Biol Phys. 2022. PMID: 34348176
74 results